DE3750125D1 - Biologische eindämmung. - Google Patents

Biologische eindämmung.

Info

Publication number
DE3750125D1
DE3750125D1 DE3750125T DE3750125T DE3750125D1 DE 3750125 D1 DE3750125 D1 DE 3750125D1 DE 3750125 T DE3750125 T DE 3750125T DE 3750125 T DE3750125 T DE 3750125T DE 3750125 D1 DE3750125 D1 DE 3750125D1
Authority
DE
Germany
Prior art keywords
host cell
immunized
antigen
replicon
animal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3750125T
Other languages
English (en)
Other versions
DE3750125T2 (de
Inventor
So Ren Molin
Poul Andersson
Kenn Gerdes
Per Klemm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
APOVIA AG, 82152 PLANEGG, DE
Original Assignee
Genexpress ApS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK145586A external-priority patent/DK145586D0/da
Priority claimed from DK629486A external-priority patent/DK629486D0/da
Application filed by Genexpress ApS filed Critical Genexpress ApS
Application granted granted Critical
Publication of DE3750125D1 publication Critical patent/DE3750125D1/de
Publication of DE3750125T2 publication Critical patent/DE3750125T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Materials For Medical Uses (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
DE3750125T 1986-03-26 1987-03-25 Biologische eindämmung. Expired - Fee Related DE3750125T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK145586A DK145586D0 (da) 1986-03-26 1986-03-26 Biologisk indeslutning
DK629486A DK629486D0 (da) 1986-12-23 1986-12-23 Biologisk indeslutning
PCT/DK1987/000031 WO1987005932A1 (en) 1986-03-26 1987-03-25 Biological containment

Publications (2)

Publication Number Publication Date
DE3750125D1 true DE3750125D1 (de) 1994-07-28
DE3750125T2 DE3750125T2 (de) 1994-10-27

Family

ID=26065777

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3750125T Expired - Fee Related DE3750125T2 (de) 1986-03-26 1987-03-25 Biologische eindämmung.

Country Status (8)

Country Link
US (2) US5853718A (de)
EP (1) EP0273040B1 (de)
JP (1) JP3090270B2 (de)
AT (1) ATE107697T1 (de)
AU (1) AU7232087A (de)
CA (1) CA1315224C (de)
DE (1) DE3750125T2 (de)
WO (1) WO1987005932A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837528A (en) 1989-06-22 1998-11-17 Hoffmann La Roche, Inc. Bacterial strains which overproduce riboflavin
CN1066486C (zh) * 1989-06-22 2001-05-30 霍夫曼-拉罗奇有限公司 高产核黄素的细菌菌株
CA2133345C (en) * 1992-04-06 1999-02-23 Sýren Molin A method of limiting the survival of genetically engineered microorganisms in their environment
US5834233A (en) * 1992-04-06 1998-11-10 Gx Biosystems A/S Method of limiting the survival of genetically engineered microorganisms in their enivronment
BE1006085A3 (fr) * 1992-07-31 1994-05-10 Univ Bruxelles Vecteur de clonage.
NZ274482A (en) * 1993-10-13 1997-09-22 Gx Biosystems As Cells transformed with a truncated and/or mutated staphylococcus aureus nuclease and their use in immunological, pesticidal and environmental pollutant-degrading compositions
WO1995034643A1 (en) * 1994-06-10 1995-12-21 Wilfried Wackernagel Conditional suicide cells of e. coli etc.
CA2264495C (en) * 1996-09-06 2007-04-17 Bioteknologisk Institut A lactic acid bacterial regulatable expression system
DE69942249D1 (de) * 1998-05-07 2010-05-27 Univ Bruxelles Auf cytotoxinen basierendes biologisches einschlusssystem
ES2286905T3 (es) 1998-12-02 2007-12-01 University Of Maryland, Baltimore Sistema de estabilizacion de plasmidos para el suministro de antigenos.
US8076130B2 (en) * 1998-12-02 2011-12-13 University Of Maryland, Baltimore Plasmid maintenance system for antigen delivery
US6413768B1 (en) 1998-12-02 2002-07-02 University Of Maryland Expression plasmids
EP1111061A1 (de) * 1999-12-20 2001-06-27 Universite Libre De Bruxelles Vektor mit doppelter Selektion
CA2435956C (en) 2001-02-23 2012-07-10 Universite Libre De Bruxelles Method for the selection of recombinant clones comprising a sequence encoding an antidote protein to toxic molecule
WO2003077863A2 (en) * 2002-03-13 2003-09-25 The Brigham And Women's Hospital, Inc. Method for overexpression of zwitterionic polysaccharides
CA2477194A1 (en) * 2002-03-19 2003-09-25 Universite Libre De Bruxelles Poison/antidote genetic systems for the selection of genetically modified eucaryote cells or organisms
US9309518B2 (en) 2002-09-03 2016-04-12 Universite Libre De Bruxelles Reversible, parallel and multitask cloning method and kit
AU2003260200A1 (en) * 2002-09-03 2004-03-29 Universite Libre De Bruxelles Reversible, parallel and multitask cloning method and kit
WO2005010144A2 (en) * 2003-04-21 2005-02-03 Wisconsin Alumni Research Foundation Displacing a plasmid in a bacterial population
WO2013009945A1 (en) 2011-07-12 2013-01-17 The Brigham And Women's Hospital, Inc. Lipid-containing psa compositions, methods of isolation and methods of use thereof
JP5947567B2 (ja) * 2012-03-02 2016-07-06 株式会社日立ハイテクノロジーズ 質量分析システム
EP3035802B1 (de) 2013-08-19 2021-07-07 Syngulon SA Kontrolliertes wachstum von mikroorganismen
WO2017031431A1 (en) 2015-08-19 2017-02-23 President And Fellows Of Harvard College Lipidated psa compositions and methods
EP3484441A4 (de) 2016-07-15 2020-03-18 President and Fellows of Harvard College Glycolipidzusammensetzungen und verfahren zur verwendung
KR20200116084A (ko) 2017-12-19 2020-10-08 신굴론 에스.에이. 발효 공정

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4506013A (en) * 1980-10-03 1985-03-19 Eli Lilly And Company Stabilizing and selecting recombinant DNA host cells
US4436815A (en) * 1981-11-27 1984-03-13 Eli Lilly And Company Method for stabilizing and selecting recombinant DNA containing host cells
US4650761A (en) * 1981-11-27 1987-03-17 Eli Lilly And Company Method for stabilizing and selecting recombinant DNA containing host cell
DK410783D0 (da) * 1982-09-16 1983-09-09 Benzon A Salfred Fremgangsmade til stabilisering af plasmider
AU569043B2 (en) * 1982-09-16 1988-01-21 Benzon Pharma A/S Plasmids with conditional uncontrolled replication behaviour
US5702916A (en) * 1982-09-16 1997-12-30 Gx Biosystems A/S Biological Containment
US4634678A (en) * 1982-12-13 1987-01-06 Molecular Genetics Research And Development Limited Partnership Plasmid cloning and expression vectors for use in microorganisms
US4767708A (en) * 1984-08-07 1988-08-30 Carnegie Mellon University Enzyme amplification and purification
DK275685D0 (da) * 1985-06-18 1985-06-18 Benzon As Alfred Stabilisering af biologiske systemer

Also Published As

Publication number Publication date
US5853718A (en) 1998-12-29
EP0273040B1 (de) 1994-06-22
EP0273040A1 (de) 1988-07-06
DE3750125T2 (de) 1994-10-27
CA1315224C (en) 1993-03-30
JPH01500002A (ja) 1989-01-12
WO1987005932A1 (en) 1987-10-08
JP3090270B2 (ja) 2000-09-18
ATE107697T1 (de) 1994-07-15
US5670370A (en) 1997-09-23
AU7232087A (en) 1987-10-20

Similar Documents

Publication Publication Date Title
DE3750125D1 (de) Biologische eindämmung.
AU2003244855A1 (en) Method to enhance an immune response of nucleic acid vaccination
ES2059361T3 (es) Complejo de proteinas recombinantes que tiene actividad de factor viii:c su produccion y uso.
DK609985D0 (da) Adhesin-antigener, antistoffer mod disse og dna-fragmenter, som indkoder antigenerne
FI791841A (fi) Foerfarande foer framstaellning av utvalt protein
ATE221916T1 (de) Synthetische dna-sequenz mit verstärkter isektizider aktivität in mais
ES2143507T3 (es) Vacunas contra la enfermedad de aujeszky y de otras enfermedades animales que contienen mutantes del virus de la pseudorrabia.
AR247761A1 (es) Metodo para producir un polipeptido en una celula hospedante de kluyveromyces, dicha celula hospedante transformada y secuencia a adn empleada
IT1196484B (it) Vettore ad espressione e secrezione in lieviti,utile per la preparazione di proteine eterologhe
Vanloubbeeck et al. The immunology of Leishmania infection and the implications for vaccine development
NO960309L (no) Agonister og antagonister for humaninterleukin-10
ATE246247T1 (de) Varianten des humanen rekombinanten interferon- gamma (rhu-ifn-gamma) mit erhöhter thermischer stabilität
DE69515340D1 (de) Impfstoff gegen mycobakterielle infektionen
MY129859A (en) Bacterial strains of the bacterium bacillus thuringiensis and uses therefor
DE3855080D1 (de) Synoviale phospholipasen
GB9720693D0 (en) Assay
KR870700096A (ko) 유용한 메탈로프로테이나제 억제제 씨퀀스 재결합 보균자계와 그의 제조를 위한 dna 재결합방법
KR890013181A (ko) 플라스모듐 팔시파럼(plasmodium falciparum)의 주위 포자소체 유전자로부터 유도된 재조합 단백질의 제조방법
DK285986A (da) Proteiner af typen human che samt fremgangsmaade til fremstilling heraf
DE60029748D1 (de) Biologische bekämpfung von nematoden
RU94046052A (ru) Гены агглютинации, дрожжи
IT8021411A0 (it) Polipeptide sintetico attivo come antigene, e procedimento per la sua preparazione.
PT870015E (pt) Novas xilanases os genes que as codificam e as suas utilizacoes
ZA916106B (en) Cloning and expression of a rhoptry-associated protein of p.falciparum
Azzali et al. Season related ultrastructural features of the parotid, submandibular and von Ebner's glands in hibernating bats.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: GX BIOSYSTEMS A/S, SOLLEROD, DK

8327 Change in the person/name/address of the patent owner

Owner name: APOVIA AG, 82152 PLANEGG, DE

8339 Ceased/non-payment of the annual fee